Medtronic has received CE mark approval for its LigaSure RAS vessel-sealing technology, expanding its Hugo robotic-assisted surgery (RAS) system capabilities for gynecologic, general, and urologic procedures in Europe.

This is the first ever robotic-driven LigaSure instrument—a new era for the vessel-sealing tech that’s been used in over 35 million procedures across more than 65 countries over the last two decades.

The instrument is powered by the company’s Valleylab FT10 energy platform and is for use exclusively with the Hugo RAS system. The LigaSure RAS instrument is indicated for sealing and cutting vessels, thick tissue, and lymphatics up to and including 7 mm in diameter. The device seals in about two seconds and minimizes thermal spread to surrounding tissue.

Dr. Miguel Caceres of Pacifica Salud Hospital in Panama was one of the first surgeons in the world to use LigaSure RAS with the Hugo RAS system.

“LigaSure technology is one of the most important advances for minimally invasive surgery because it provides sealing and cutting in a way that is very, very secure for the performance of the surgeon and the security of the patient,” said Dr. Caceres. “As a robotic surgeon, we want LigaSure technology because it gives us confidence in the security of the seal. We are already seeing the benefits in our cases with the Hugo RAS system.”

In April, Medtronic announced that it submitted the surgical robotic system to the U.S. Food and Drug Administration (FDA) for a urologic indication. The company expects U.S. entrance later in its current fiscal year, with planned indication expansions into hernia and gynecology.

“Today, with CE Mark for LigaSure RAS, Medtronic is fulfilling a promise to customers to integrate our trusted vessel-sealing technology onto the Hugo RAS system,” said Matt Anderson, senior vice president and president of the Surgical business, which is part of the Medical Surgical Portfolio at Medtronic. “More than fulfilling a commitment, this regulatory approval is a big step forward as we continue to shape the future of surgery with surgical teams who share our passion and commitment to deliver the best possible care to every patient.”